Gilder Gagnon Howe & Co’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.31M | Buy |
191,115
+176,253
| +1,186% | +$5.82M | 0.07% | 131 |
|
|
2025
Q1 | $597K | Buy |
14,862
+2,970
| +25% | +$119K | 0.01% | 207 |
|
|
2024
Q4 | $559K | Sell |
11,892
-1,663
| -12% | -$78.2K | 0.01% | 229 |
|
|
2024
Q3 | $716K | Sell |
13,555
-275
| -2% | -$14.5K | 0.01% | 222 |
|
|
2024
Q2 | $749K | Sell |
13,830
-221
| -2% | -$12K | 0.01% | 216 |
|
|
2024
Q1 | $985K | Sell |
14,051
-12,294
| -47% | -$862K | 0.01% | 209 |
|
|
2023
Q4 | $2.2M | Sell |
26,345
-188
| -0.7% | -$15.7K | 0.03% | 175 |
|
|
2023
Q3 | $782K | Buy |
26,533
+69
| +0.3% | +$2.03K | 0.01% | 219 |
|
|
2023
Q2 | $863K | Sell |
26,464
-373
| -1% | -$12.2K | 0.01% | 232 |
|
|
2023
Q1 | $944K | Sell |
26,837
-483
| -2% | -$17K | 0.02% | 198 |
|
|
2022
Q4 | $1.25M | Buy |
27,320
+1,485
| +6% | +$68K | 0.02% | 191 |
|
|
2022
Q3 | $1.25M | Buy |
+25,835
| New | +$1.25M | 0.02% | 190 |
|